Literature DB >> 2308009

Residual mass and negative gallium scintigraphy in treated lymphoma: when is the gallium scan really negative?

W D Kaplan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2308009

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  6 in total

Review 1.  Gallium-67 scintigraphy: a cornerstone in functional imaging of lymphoma.

Authors:  Einat Even-Sapir; Ora Israel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-18       Impact factor: 9.236

2.  The role of gallium-67 tumour scintigraphy in patients with small, non-cleaved cell lymphoma.

Authors:  D Sandrock; S Lastoria; I T Magrath; R D Neumann
Journal:  Eur J Nucl Med       Date:  1993-02

Review 3.  From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.

Authors:  Richard L Wahl; Heather Jacene; Yvette Kasamon; Martin A Lodge
Journal:  J Nucl Med       Date:  2009-05       Impact factor: 10.057

4.  Hypophyseal non-Hodgkin's lymphoma presenting with clinical panhypopituitarism successfully treated with chemotherapy.

Authors:  A R Jonkhoff; P C Huijgens; W O Schreuder; G J Teule; J J Heimans
Journal:  J Neurooncol       Date:  1993-08       Impact factor: 4.130

Review 5.  The role of SPET and PET in monitoring tumour response to therapy.

Authors:  Chariklia Giannopoulou
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-06-14       Impact factor: 9.236

6.  Residual mass after treatment of primary cervical lymphoma: the utility of gallium 67 and MRI.

Authors:  C J Kasales; J E Langer; C T Young; K Singapuri; P H Arger
Journal:  Abdom Imaging       Date:  1994 May-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.